nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Lisinopril—systemic scleroderma	0.205	0.328	CbGbCtD
Mannitol—ABCB1—Captopril—systemic scleroderma	0.153	0.246	CbGbCtD
Mannitol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.121	0.194	CbGbCtD
Mannitol—ABCB1—Prednisone—systemic scleroderma	0.0966	0.155	CbGbCtD
Mannitol—ABCB1—Methotrexate—systemic scleroderma	0.0484	0.0776	CbGbCtD
Mannitol—Skin disorder—Azathioprine—systemic scleroderma	0.000493	0.00131	CcSEcCtD
Mannitol—Nervousness—Lisinopril—systemic scleroderma	0.00049	0.0013	CcSEcCtD
Mannitol—Cough—Mycophenolic acid—systemic scleroderma	0.000488	0.0013	CcSEcCtD
Mannitol—Back pain—Lisinopril—systemic scleroderma	0.000488	0.0013	CcSEcCtD
Mannitol—Vomiting—Pentoxifylline—systemic scleroderma	0.000487	0.0013	CcSEcCtD
Mannitol—Convulsion—Mycophenolic acid—systemic scleroderma	0.000485	0.00129	CcSEcCtD
Mannitol—Rash—Pentoxifylline—systemic scleroderma	0.000483	0.00129	CcSEcCtD
Mannitol—Hypertension—Mycophenolic acid—systemic scleroderma	0.000483	0.00129	CcSEcCtD
Mannitol—Dermatitis—Pentoxifylline—systemic scleroderma	0.000483	0.00129	CcSEcCtD
Mannitol—Headache—Pentoxifylline—systemic scleroderma	0.00048	0.00128	CcSEcCtD
Mannitol—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00048	0.00128	CcSEcCtD
Mannitol—Feeling abnormal—Captopril—systemic scleroderma	0.000479	0.00127	CcSEcCtD
Mannitol—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000478	0.00127	CcSEcCtD
Mannitol—Chest pain—Mycophenolic acid—systemic scleroderma	0.000477	0.00127	CcSEcCtD
Mannitol—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000477	0.00127	CcSEcCtD
Mannitol—Infection—Leflunomide—systemic scleroderma	0.000476	0.00127	CcSEcCtD
Mannitol—Vision blurred—Lisinopril—systemic scleroderma	0.000475	0.00126	CcSEcCtD
Mannitol—Asthenia—Mometasone—systemic scleroderma	0.000475	0.00126	CcSEcCtD
Mannitol—Hypotension—Azathioprine—systemic scleroderma	0.000474	0.00126	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000473	0.00126	CcSEcCtD
Mannitol—Polyuria—Methotrexate—systemic scleroderma	0.000473	0.00126	CcSEcCtD
Mannitol—Discomfort—Mycophenolic acid—systemic scleroderma	0.000471	0.00125	CcSEcCtD
Mannitol—Nervous system disorder—Leflunomide—systemic scleroderma	0.00047	0.00125	CcSEcCtD
Mannitol—Pruritus—Mometasone—systemic scleroderma	0.000468	0.00125	CcSEcCtD
Mannitol—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000468	0.00124	CcSEcCtD
Mannitol—Tachycardia—Leflunomide—systemic scleroderma	0.000467	0.00124	CcSEcCtD
Mannitol—Skin disorder—Leflunomide—systemic scleroderma	0.000465	0.00124	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000462	0.00123	CcSEcCtD
Mannitol—Body temperature increased—Captopril—systemic scleroderma	0.000459	0.00122	CcSEcCtD
Mannitol—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00122	CcSEcCtD
Mannitol—Oedema—Mycophenolic acid—systemic scleroderma	0.000457	0.00122	CcSEcCtD
Mannitol—Nausea—Pentoxifylline—systemic scleroderma	0.000455	0.00121	CcSEcCtD
Mannitol—Chills—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00121	CcSEcCtD
Mannitol—Malaise—Lisinopril—systemic scleroderma	0.000455	0.00121	CcSEcCtD
Mannitol—Infection—Mycophenolic acid—systemic scleroderma	0.000454	0.00121	CcSEcCtD
Mannitol—Vertigo—Lisinopril—systemic scleroderma	0.000453	0.00121	CcSEcCtD
Mannitol—Diarrhoea—Mometasone—systemic scleroderma	0.000453	0.0012	CcSEcCtD
Mannitol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000448	0.00119	CcSEcCtD
Mannitol—Hypotension—Leflunomide—systemic scleroderma	0.000447	0.00119	CcSEcCtD
Mannitol—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000446	0.00119	CcSEcCtD
Mannitol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00118	CcSEcCtD
Mannitol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000444	0.00118	CcSEcCtD
Mannitol—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00118	CcSEcCtD
Mannitol—Cough—Lisinopril—systemic scleroderma	0.00044	0.00117	CcSEcCtD
Mannitol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000438	0.00116	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000436	0.00116	CcSEcCtD
Mannitol—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00116	CcSEcCtD
Mannitol—Chest pain—Lisinopril—systemic scleroderma	0.000429	0.00114	CcSEcCtD
Mannitol—Arthralgia—Lisinopril—systemic scleroderma	0.000429	0.00114	CcSEcCtD
Mannitol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00114	CcSEcCtD
Mannitol—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00114	CcSEcCtD
Mannitol—Dyspnoea—Leflunomide—systemic scleroderma	0.000427	0.00114	CcSEcCtD
Mannitol—Hypotension—Mycophenolic acid—systemic scleroderma	0.000427	0.00114	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000426	0.00113	CcSEcCtD
Mannitol—Discomfort—Lisinopril—systemic scleroderma	0.000424	0.00113	CcSEcCtD
Mannitol—Vomiting—Mometasone—systemic scleroderma	0.000421	0.00112	CcSEcCtD
Mannitol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000418	0.00111	CcSEcCtD
Mannitol—Rash—Mometasone—systemic scleroderma	0.000417	0.00111	CcSEcCtD
Mannitol—Asthenia—Captopril—systemic scleroderma	0.000417	0.00111	CcSEcCtD
Mannitol—Dermatitis—Mometasone—systemic scleroderma	0.000417	0.00111	CcSEcCtD
Mannitol—Decreased appetite—Leflunomide—systemic scleroderma	0.000416	0.00111	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000416	0.00111	CcSEcCtD
Mannitol—Headache—Mometasone—systemic scleroderma	0.000414	0.0011	CcSEcCtD
Mannitol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000413	0.0011	CcSEcCtD
Mannitol—Fatigue—Leflunomide—systemic scleroderma	0.000413	0.0011	CcSEcCtD
Mannitol—Oedema—Lisinopril—systemic scleroderma	0.000411	0.00109	CcSEcCtD
Mannitol—Pruritus—Captopril—systemic scleroderma	0.000411	0.00109	CcSEcCtD
Mannitol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00109	CcSEcCtD
Mannitol—Pain—Leflunomide—systemic scleroderma	0.00041	0.00109	CcSEcCtD
Mannitol—Infection—Lisinopril—systemic scleroderma	0.000409	0.00109	CcSEcCtD
Mannitol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000407	0.00108	CcSEcCtD
Mannitol—Tachycardia—Lisinopril—systemic scleroderma	0.000402	0.00107	CcSEcCtD
Mannitol—Body temperature increased—Azathioprine—systemic scleroderma	0.000401	0.00107	CcSEcCtD
Mannitol—Skin disorder—Lisinopril—systemic scleroderma	0.0004	0.00106	CcSEcCtD
Mannitol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00106	CcSEcCtD
Mannitol—Diarrhoea—Captopril—systemic scleroderma	0.000398	0.00106	CcSEcCtD
Mannitol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000397	0.00106	CcSEcCtD
Mannitol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00106	CcSEcCtD
Mannitol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000395	0.00105	CcSEcCtD
Mannitol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000394	0.00105	CcSEcCtD
Mannitol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000394	0.00105	CcSEcCtD
Mannitol—Nausea—Mometasone—systemic scleroderma	0.000393	0.00105	CcSEcCtD
Mannitol—Pain—Mycophenolic acid—systemic scleroderma	0.000391	0.00104	CcSEcCtD
Mannitol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000385	0.00103	CcSEcCtD
Mannitol—Hypotension—Lisinopril—systemic scleroderma	0.000385	0.00102	CcSEcCtD
Mannitol—Dizziness—Captopril—systemic scleroderma	0.000384	0.00102	CcSEcCtD
Mannitol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00102	CcSEcCtD
Mannitol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00101	CcSEcCtD
Mannitol—Urticaria—Leflunomide—systemic scleroderma	0.00038	0.00101	CcSEcCtD
Mannitol—Body temperature increased—Leflunomide—systemic scleroderma	0.000379	0.00101	CcSEcCtD
Mannitol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000376	0.001	CcSEcCtD
Mannitol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.001	CcSEcCtD
Mannitol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000376	0.001	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000375	0.000998	CcSEcCtD
Mannitol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000374	0.000994	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000994	CcSEcCtD
Mannitol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000989	CcSEcCtD
Mannitol—Vomiting—Captopril—systemic scleroderma	0.000369	0.000983	CcSEcCtD
Mannitol—Dyspnoea—Lisinopril—systemic scleroderma	0.000367	0.000976	CcSEcCtD
Mannitol—Rash—Captopril—systemic scleroderma	0.000366	0.000975	CcSEcCtD
Mannitol—Dermatitis—Captopril—systemic scleroderma	0.000366	0.000974	CcSEcCtD
Mannitol—Headache—Captopril—systemic scleroderma	0.000364	0.000969	CcSEcCtD
Mannitol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000361	0.000961	CcSEcCtD
Mannitol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000959	CcSEcCtD
Mannitol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000953	CcSEcCtD
Mannitol—Decreased appetite—Lisinopril—systemic scleroderma	0.000358	0.000952	CcSEcCtD
Mannitol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000355	0.000945	CcSEcCtD
Mannitol—Fatigue—Lisinopril—systemic scleroderma	0.000355	0.000944	CcSEcCtD
Mannitol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000941	CcSEcCtD
Mannitol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000353	0.000939	CcSEcCtD
Mannitol—Pain—Lisinopril—systemic scleroderma	0.000352	0.000936	CcSEcCtD
Mannitol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000936	CcSEcCtD
Mannitol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000932	CcSEcCtD
Mannitol—Diarrhoea—Azathioprine—systemic scleroderma	0.000347	0.000923	CcSEcCtD
Mannitol—Nausea—Captopril—systemic scleroderma	0.000345	0.000918	CcSEcCtD
Mannitol—Asthenia—Leflunomide—systemic scleroderma	0.000344	0.000914	CcSEcCtD
Mannitol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000339	0.000902	CcSEcCtD
Mannitol—Pruritus—Leflunomide—systemic scleroderma	0.000339	0.000902	CcSEcCtD
Mannitol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000338	0.000899	CcSEcCtD
Mannitol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000896	CcSEcCtD
Mannitol—Dizziness—Azathioprine—systemic scleroderma	0.000335	0.000892	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000334	0.000888	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000874	CcSEcCtD
Mannitol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000328	0.000872	CcSEcCtD
Mannitol—Diarrhoea—Leflunomide—systemic scleroderma	0.000328	0.000872	CcSEcCtD
Mannitol—Urticaria—Lisinopril—systemic scleroderma	0.000327	0.00087	CcSEcCtD
Mannitol—Body temperature increased—Lisinopril—systemic scleroderma	0.000325	0.000866	CcSEcCtD
Mannitol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000323	0.00086	CcSEcCtD
Mannitol—Vomiting—Azathioprine—systemic scleroderma	0.000322	0.000858	CcSEcCtD
Mannitol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000855	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—systemic scleroderma	0.00032	0.000852	CcSEcCtD
Mannitol—Infestation—Methotrexate—systemic scleroderma	0.00032	0.000852	CcSEcCtD
Mannitol—Rash—Azathioprine—systemic scleroderma	0.00032	0.000851	CcSEcCtD
Mannitol—Dermatitis—Azathioprine—systemic scleroderma	0.000319	0.00085	CcSEcCtD
Mannitol—Headache—Azathioprine—systemic scleroderma	0.000318	0.000845	CcSEcCtD
Mannitol—Dizziness—Leflunomide—systemic scleroderma	0.000317	0.000843	CcSEcCtD
Mannitol—Renal failure—Methotrexate—systemic scleroderma	0.000315	0.000838	CcSEcCtD
Mannitol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000834	CcSEcCtD
Mannitol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000313	0.000832	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—systemic scleroderma	0.000312	0.000831	CcSEcCtD
Mannitol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000828	CcSEcCtD
Mannitol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00082	CcSEcCtD
Mannitol—Vomiting—Leflunomide—systemic scleroderma	0.000304	0.00081	CcSEcCtD
Mannitol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000303	0.000807	CcSEcCtD
Mannitol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000302	0.000804	CcSEcCtD
Mannitol—Rash—Leflunomide—systemic scleroderma	0.000302	0.000803	CcSEcCtD
Mannitol—Dermatitis—Leflunomide—systemic scleroderma	0.000302	0.000803	CcSEcCtD
Mannitol—Mental disorder—Prednisone—systemic scleroderma	0.000301	0.000802	CcSEcCtD
Mannitol—Nausea—Azathioprine—systemic scleroderma	0.000301	0.000801	CcSEcCtD
Mannitol—Headache—Leflunomide—systemic scleroderma	0.0003	0.000798	CcSEcCtD
Mannitol—Malnutrition—Prednisone—systemic scleroderma	0.000299	0.000797	CcSEcCtD
Mannitol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000791	CcSEcCtD
Mannitol—Asthenia—Lisinopril—systemic scleroderma	0.000295	0.000786	CcSEcCtD
Mannitol—Pruritus—Lisinopril—systemic scleroderma	0.000291	0.000775	CcSEcCtD
Mannitol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00029	0.000773	CcSEcCtD
Mannitol—Rash—Mycophenolic acid—systemic scleroderma	0.000288	0.000766	CcSEcCtD
Mannitol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000288	0.000766	CcSEcCtD
Mannitol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000762	CcSEcCtD
Mannitol—Headache—Mycophenolic acid—systemic scleroderma	0.000286	0.000762	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—systemic scleroderma	0.000285	0.000759	CcSEcCtD
Mannitol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000758	CcSEcCtD
Mannitol—Nausea—Leflunomide—systemic scleroderma	0.000284	0.000757	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000284	0.000755	CcSEcCtD
Mannitol—Vision blurred—Prednisone—systemic scleroderma	0.000282	0.000751	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—systemic scleroderma	0.000282	0.00075	CcSEcCtD
Mannitol—Diarrhoea—Lisinopril—systemic scleroderma	0.000282	0.000749	CcSEcCtD
Mannitol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000278	0.000739	CcSEcCtD
Mannitol—Dizziness—Lisinopril—systemic scleroderma	0.000272	0.000724	CcSEcCtD
Mannitol—Nausea—Mycophenolic acid—systemic scleroderma	0.000271	0.000722	CcSEcCtD
Mannitol—Malaise—Prednisone—systemic scleroderma	0.00027	0.000719	CcSEcCtD
Mannitol—Vertigo—Prednisone—systemic scleroderma	0.000269	0.000716	CcSEcCtD
Mannitol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000707	CcSEcCtD
Mannitol—Vomiting—Lisinopril—systemic scleroderma	0.000262	0.000696	CcSEcCtD
Mannitol—Rash—Lisinopril—systemic scleroderma	0.000259	0.00069	CcSEcCtD
Mannitol—Convulsion—Prednisone—systemic scleroderma	0.000259	0.00069	CcSEcCtD
Mannitol—Dermatitis—Lisinopril—systemic scleroderma	0.000259	0.00069	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000259	0.000689	CcSEcCtD
Mannitol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000688	CcSEcCtD
Mannitol—Hypertension—Prednisone—systemic scleroderma	0.000259	0.000688	CcSEcCtD
Mannitol—Chills—Methotrexate—systemic scleroderma	0.000258	0.000686	CcSEcCtD
Mannitol—Headache—Lisinopril—systemic scleroderma	0.000258	0.000686	CcSEcCtD
Mannitol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000679	CcSEcCtD
Mannitol—Arthralgia—Prednisone—systemic scleroderma	0.000255	0.000678	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000253	0.000674	CcSEcCtD
Mannitol—Discomfort—Prednisone—systemic scleroderma	0.000252	0.00067	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—systemic scleroderma	0.000252	0.00067	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—systemic scleroderma	0.00025	0.000666	CcSEcCtD
Mannitol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000656	CcSEcCtD
Mannitol—Nausea—Lisinopril—systemic scleroderma	0.000244	0.00065	CcSEcCtD
Mannitol—Oedema—Prednisone—systemic scleroderma	0.000244	0.00065	CcSEcCtD
Mannitol—Infection—Prednisone—systemic scleroderma	0.000243	0.000646	CcSEcCtD
Mannitol—Back pain—Methotrexate—systemic scleroderma	0.000242	0.000644	CcSEcCtD
Mannitol—Nervous system disorder—Prednisone—systemic scleroderma	0.00024	0.000638	CcSEcCtD
Mannitol—Tachycardia—Prednisone—systemic scleroderma	0.000239	0.000635	CcSEcCtD
Mannitol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000634	CcSEcCtD
Mannitol—Skin disorder—Prednisone—systemic scleroderma	0.000237	0.000632	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—systemic scleroderma	0.000236	0.000628	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000232	0.000618	CcSEcCtD
Mannitol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00061	CcSEcCtD
Mannitol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000605	CcSEcCtD
Mannitol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000604	CcSEcCtD
Mannitol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000601	CcSEcCtD
Mannitol—Malaise—Methotrexate—systemic scleroderma	0.000226	0.000601	CcSEcCtD
Mannitol—Vertigo—Methotrexate—systemic scleroderma	0.000225	0.000598	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000223	0.000592	CcSEcCtD
Mannitol—Cough—Methotrexate—systemic scleroderma	0.000218	0.000581	CcSEcCtD
Mannitol—Convulsion—Methotrexate—systemic scleroderma	0.000217	0.000577	CcSEcCtD
Mannitol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00057	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—systemic scleroderma	0.000213	0.000567	CcSEcCtD
Mannitol—Chest pain—Methotrexate—systemic scleroderma	0.000213	0.000567	CcSEcCtD
Mannitol—Decreased appetite—Prednisone—systemic scleroderma	0.000212	0.000565	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000212	0.000563	CcSEcCtD
Mannitol—Fatigue—Prednisone—systemic scleroderma	0.000211	0.000561	CcSEcCtD
Mannitol—Discomfort—Methotrexate—systemic scleroderma	0.000211	0.00056	CcSEcCtD
Mannitol—Infection—Methotrexate—systemic scleroderma	0.000203	0.00054	CcSEcCtD
Mannitol—Feeling abnormal—Prednisone—systemic scleroderma	0.000201	0.000536	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—systemic scleroderma	0.0002	0.000533	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—systemic scleroderma	0.000198	0.000528	CcSEcCtD
Mannitol—Urticaria—Prednisone—systemic scleroderma	0.000194	0.000517	CcSEcCtD
Mannitol—Body temperature increased—Prednisone—systemic scleroderma	0.000193	0.000514	CcSEcCtD
Mannitol—Hypotension—Methotrexate—systemic scleroderma	0.000191	0.000508	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000186	0.000495	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—systemic scleroderma	0.000182	0.000485	CcSEcCtD
Mannitol—Hypersensitivity—Prednisone—systemic scleroderma	0.00018	0.000479	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—systemic scleroderma	0.000178	0.000472	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000176	0.000469	CcSEcCtD
Mannitol—Fatigue—Methotrexate—systemic scleroderma	0.000176	0.000469	CcSEcCtD
Mannitol—Asthenia—Prednisone—systemic scleroderma	0.000175	0.000467	CcSEcCtD
Mannitol—Pain—Methotrexate—systemic scleroderma	0.000175	0.000465	CcSEcCtD
Mannitol—Pruritus—Prednisone—systemic scleroderma	0.000173	0.00046	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000168	0.000448	CcSEcCtD
Mannitol—Diarrhoea—Prednisone—systemic scleroderma	0.000167	0.000445	CcSEcCtD
Mannitol—Urticaria—Methotrexate—systemic scleroderma	0.000162	0.000432	CcSEcCtD
Mannitol—Dizziness—Prednisone—systemic scleroderma	0.000162	0.00043	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—systemic scleroderma	0.000161	0.00043	CcSEcCtD
Mannitol—Vomiting—Prednisone—systemic scleroderma	0.000155	0.000413	CcSEcCtD
Mannitol—Rash—Prednisone—systemic scleroderma	0.000154	0.00041	CcSEcCtD
Mannitol—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.00041	CcSEcCtD
Mannitol—Headache—Prednisone—systemic scleroderma	0.000153	0.000407	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00015	0.0004	CcSEcCtD
Mannitol—Asthenia—Methotrexate—systemic scleroderma	0.000147	0.00039	CcSEcCtD
Mannitol—Nausea—Prednisone—systemic scleroderma	0.000145	0.000386	CcSEcCtD
Mannitol—Pruritus—Methotrexate—systemic scleroderma	0.000145	0.000385	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.000372	CcSEcCtD
Mannitol—Dizziness—Methotrexate—systemic scleroderma	0.000135	0.000359	CcSEcCtD
Mannitol—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.000346	CcSEcCtD
Mannitol—Rash—Methotrexate—systemic scleroderma	0.000129	0.000343	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.000342	CcSEcCtD
Mannitol—Headache—Methotrexate—systemic scleroderma	0.000128	0.00034	CcSEcCtD
Mannitol—Nausea—Methotrexate—systemic scleroderma	0.000121	0.000323	CcSEcCtD
